What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?
A key feature of emerging markets is that patients often have to self-fund a high proportion of their healthcare costs. While private health insurance coverage is increasing in many emerging markets, penetration typically remains low, even among middle to high income segments of the population.
How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider. Research Partnership